Clinical Trials Browser

INDUSTRY × Glioma × Craniotomy × Clear all

NCT00805376 2018-07-16

DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas

Phase 1 Completed

Brain Neoplasms, Central Nervous System Diseases, Glioma